Helix scores $50m Series C
Helix, a population genomics and COVID-19 testing company, has raised $50 million in Series C funding.
Helix, a population genomics and COVID-19 testing company, has raised $50 million in Series C funding.
Copyright PEI Media
Not for publication, email or dissemination